Correlation Between Dermata Therapeutics and VTv Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and vTv Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and VTv Therapeutics.

Diversification Opportunities for Dermata Therapeutics and VTv Therapeutics

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dermata and VTv is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and VTv Therapeutics go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and VTv Therapeutics

Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.64 times more return on investment than VTv Therapeutics. However, Dermata Therapeutics is 1.64 times more volatile than vTv Therapeutics. It trades about 0.23 of its potential returns per unit of risk. vTv Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  105.00  in Dermata Therapeutics on October 20, 2024 and sell it today you would earn a total of  28.00  from holding Dermata Therapeutics or generate 26.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dermata Therapeutics  vs.  vTv Therapeutics

 Performance 
       Timeline  
Dermata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Dermata Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
vTv Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, VTv Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Dermata Therapeutics and VTv Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dermata Therapeutics and VTv Therapeutics

The main advantage of trading using opposite Dermata Therapeutics and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.
The idea behind Dermata Therapeutics and vTv Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data